Immunoglobulin G subclass responses to recombinant Em18 in the follow-up of patients with alveolar echinococcosis in different clinical stages.
In this study, we compared the sequential responses of immunoglobulin G (IgG) subclasses to the diagnostic antigen Em18 in sera from patients with alveolar echinococcosis. A total of 225 sera from 36 patients at different clinical stages according to the WHO-PNM staging system were tested. The antibody responses were measured for cohorts with resected and unresected parasitic lesions by enzyme-linked immunosorbent assays (ELISA). Total IgG and, to a lesser extent, IgG4 antibody levels against Em18 correlated with all PNM stages before treatment, whereas levels of IgG2 were low and IgG3 was undetectable. Antibody kinetics, however, depended on the treatment rather than on the PNM stage. For some patients, after curative surgery, IgG1 antibodies dropped below the cutoff earlier than other antibodies, followed by total IgG and IgG4 within 18 months. For some patients with recurrences after surgery, IgG1 and IgG4 reappeared, whereas patients with unresectable lesions but stable disease showed steady declines in the levels of all antibodies, and IgG1 became undetectable in some patients. Additional testing of IgE responses to Em18 showed constantly low levels at all stages and in all cohorts.
Tappe
Dennis
D
Institute of Hygiene and Microbiology, Josef-Schneider-Str. 2, 97080 Würzburg, Germany. dtappe@hygiene.uni-wuerzburg.de
Sako
Yasuhito
Y
Itoh
Sonoyo
S
Frosch
Matthias
M
Grüner
Beate
B
Kern
Peter
P
Ito
Akira
A
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000909:Antibodies, Helminth / Q000097:blood* / Q000145:classification; D000947:Antigens, Helminth / Q000235:genetics / Q000276:immunology*; D004445:Echinococcosis, Pulmonary / Q000276:immunology* / Q000469:parasitology / Q000503:physiopathology*; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D005858:Germany; D006801:Humans; D007074:Immunoglobulin G / Q000097:blood* / Q000145:classification; D008297:Male; D008875:Middle Aged; D011994:Recombinant Proteins / Q000235:genetics / Q000276:immunology*; D055815:Young Adult
D000909:Antibodies, Helminth; D000947:Antigens, Helminth; C117889:Em18 antigen; D007074:Immunoglobulin G; D011994:Recombinant Proteins
J Clin Microbiol. 2002 Nov;40(11):4161-5
12409391
Am J Trop Med Hyg. 2009 May;80(5):792-7
19407126
Trop Med Int Health. 1997 Aug;2(8):779-87
9294548
Ann Trop Med Parasitol. 1995 Oct;89(5):485-95
7495362
Am J Trop Med Hyg. 1994 Dec;51(6):741-8
7810806
J Hepatol. 2004 Oct;41(4):551-9
15532108
Parasitol Int. 2006;55 Suppl:S283-7
16343985
Trans R Soc Trop Med Hyg. 1995 Nov-Dec;89(6):692-7
8594699
J Allergy Clin Immunol. 2009 Jun;123(6):1268-76.e15
19443021
Clin Vaccine Immunol. 2010 Mar;17(3):470-5
20042519
Diagn Microbiol Infect Dis. 2007 Sep;59(1):93-5
17509798
Am J Trop Med Hyg. 1995 Jan;52(1):41-4
7531957
J Clin Microbiol. 2009 Oct;47(10):3191-6
19656973
Schweiz Med Wochenschr. 1995 Oct 21;125(42):1989-98
7481657
Trans R Soc Trop Med Hyg. 1997 Jul-Aug;91(4):476-8
9373660
Antimicrob Agents Chemother. 2003 Nov;47(11):3586-91
14576122
Gastroenterol Clin North Am. 1996 Sep;25(3):655-89
8863045
J Clin Microbiol. 2002 Aug;40(8):2760-5
12149326
Am J Trop Med Hyg. 1983 Nov;32(6):1381-6
6650740
J Gastroenterol. 2005 Apr;40(4):426-31
15870979